We studied two families from Galicia (northwest Spain) with Pendred syndrome (PS) and unusual thyroid phenotypes. In family A, the proposita had a large goiter and hypothyroxinemia but normal TSH and free T 3 (FT 3 ). In family B, some affected members showed deafness but not goiter.
chloride, formate, and nitrate transport (3) . SLC26A4 mutations arealsoimplicatedinneurosensorynonsyndromicrecessivedeafness4, DFNB4, with inner ear malformations (4, 5) . Around 150 mutations in SLC26A4 have been reported (http://www.medicine.uiowa.edu/ pendredandbor/listed_mutations.htm). Different populations are affected by different mutations, and founder mutations have been reported in a few cases (4 -17) .
In the thyroid gland, pendrin acts at the apical pole of thyrocytes to transport intracellular iodide into the follicular lumen (18) . Loss of pendrin function causes a failure in iodine supply and an organification defect often leading to euthyroid goiters (8, 10, 12, 16, 19) similar to those seen in iodine-deficient areas (20) . We report two unrelated families with PS who have a thymidine deletion c.279delT at exon 3, resulting from a founder mutation. A thyrocyte cell line, T-PS2, was obtained from a primary thyroid culture of the family B propositus, providing data on the effects of the c.279delT and c.416 -1G3 A mutations on mutated pendrin localization and iodine handling in affected thyrocytes.
Subjects and Methods

Subjects
Family A
The proposita was a 43-yr-old deaf woman with grade III asymmetric multinodular goiter (Fig. 1) . Neither her parents nor her three siblings were deaf. Although serum free T 4 (FT 4 ) was low (0.51 ng/dl, 6.56 pmol/ liter; normal range 0.85-1.69 ng/dl), her serum TSH, FT 3 , and rT 3 were normal; serum thyroglobulin (Tg) was 1312 ng/ml (normal range 0 -80 ng/ml), anti-thyroperoxidase (anti-TPO) and anti-Tg antibodies were negative, and urine iodine was 102 g/liter (median value for her age in our population is 79.7 g/liter). A computer tomography scan showed enlarged vestibular aqueducts. A perchlorate test showed an organification defect. Increasing daily doses of L-thyroxine (25, 50, 75, and 100 g) were given, but her serum FT 4 levels remained low or low-normal. A total thyroidectomy was performed (Fig. 1) , and the patient was discharged on 100 g L-thyroxine daily.
Family B
The propositus, a 26-yr-old deaf male, was referred to us for hypothyroidism. He was the only child of a nonconsanguineous deaf couple A B with a strong family history of deafness and goiter (Fig. 2 ). He had a goiter with a 1-cm nodule in the right lobe. Serum TSH was 7.08 U/ml, with low FT 4 (0.73 ng/dl, 9.40 pmol/liter) and normal FT 3 . Anti-TPO and -Tg antibodies were negative. A fine-needle aspiration cytology was suggestive of follicular neoplasia, and a right hemithyroidectomy was performed. The propositus' mother had a grade II goiter, whereas his father had neither goiter nor abnormal serum levels of thyroid hormone, although a perchlorate test did show a partial organification defect. Both parents presented with profound neonatal deafness, as did two of the mother's four siblings and two of the father's seven siblings. One of the father's brothers (subject IIIB.3, Fig. 2 ) showed much less severe deafness starting in childhood.
Genetic studies
Genomic DNA was extracted from blood cells of the propositi, 10 members of their families, and 50 normal volunteers (age range 20 -60 yr) and from thyroid tissues of the propositi and 60 control subjects (healthy parts of surgically removed multinodular goiters). All exons of the SLC26A4 gene were amplified by PCR (primer sequences and PCR conditions available upon request) and sequenced in an ABI PRISM 3100 (Applied Biosystems, Foster City, CA). The study was approved by our Institutional Review Board, and informed consents were obtained.
For haplotype analysis, four polymorphic markers closely linked to SLC26A4 were genotyped. According to the NCBI STS map, D7S2459 is located in SLC26A4 intron 10, and D7S2420 and D7S496 are proximal and D7S2456 distal to SLC26A4. Oligonucleotide primer sequences were obtained from http://www.ncbi.nlm.nih.gov, and forward primers were fluorescence labeled. PCR products were electrophoresed in a MegaBace 500 (Amersham Pharmacia Biotech, Piscataway, NJ). Alleles were numbered according to product size.
Effects of the intronic mutation on SLC26A4 were investigated in skin fibroblasts and thyroid tissue from the B propositus. cDNA fragments spanning from exon 3 to exon 6 were PCR amplified and cloned into a pGEMT-Easy vector (Promega, Madison, WI), and the products were sequenced as described.
Determination of type 1 and type 2 iodothyronine deiodinases (D1 and D2) and MCT8
D1, D2, and MCT8 mRNA levels and D1 and D2 activities were measured in thyroid tissue from the A proposita and from healthy parts of six surgically derived thyroid specimens and two toxic follicular adenomas.
MCT8, D1, and D2 mRNAs and the internal control RNA polymerase II were quantified in a Light Cycler 2.0 (Roche, Indianapolis, IN) using specific probes and oligonucleotide primers designed by Universal ProbeLibrary (Roche). Real-time PCR conditions are available upon request. Results were normalized for RNA polymerase II, using the 2 Ϫ⌬⌬CT method (21) .
D1 and D2 activities were measured in thyroid tissue homogenates as described (22, 23) .
Thyroid hormone levels in thyroid gland samples were determined by in-house RIAs (24). 
Histological and immunohistochemical studies
Immunohistochemical studies were performed on paraffin sections of thyroid specimens from the two propositi using an EnVision peroxidase/ diaminobenzidine kit with antibodies to thyroid transcription factor-1 (Dako, Carpinteria, CA; dilution 1:50), Tg (Tg6 , recognizing the first 15 amino acids of human pendrin, denominated pendrin1 (25), was also used. Negative controls in which the primary antibodies were replaced by nonimmune mouse serum, and positive controls such as normal thyroid tissue from autopsy and surgical thyroid tissue from a subject with Graves' disease, were included.
Cell culture, immunoblotting, and immunofluorescence analysis
Thyrocyte cell lines from the B propositus thyroid gland (T-PS2), from a normal thyroid tissue specimen (NT), and from a cold follicular adenoma (T-FA6) were obtained as previously described (26).
Amounts of the sodium-iodide symporter (NIS) and pendrin were estimated by Western blot of protein extracts. Low-detergent extracts to assess cytoplasmic membrane contents [endoplasmic reticulum (ER) and Golgi], and total extracts to include plasma membrane proteins, were prepared as described (27, 28). Immunodetection was carried out with antibodies to NIS (1:300; Chemicon, Temecula, CA), PS1Ab (1:300) and tubulin (1:5000; Sigma Chemical Co., St. Louis, MO). Bound antibodies were detected with alkaline phosphatase-labeled secondary antibodies (Tropix, Bedford, MA).
Immunofluorescence assays were done in cells seeded onto glass coverslips, fixed with 1% paraformaldehyde for 20 min, permeabilized with Triton 1% for 10 min at room temperature, and then quenched with 50 mM NH 4 Cl for 1 h. Alternatively, cells were fixed with ice-cold methanol for 10 min. Antibodies used were the Chemicon anti-NIS (1:50) and PS1Ab (1:20, methanol-fixed cells) or PS5Ab, which recognizes the last 13 carboxyl-terminal amino acids of human pendrin, denominated pendrin5 (1:20, paraformaldehyde-fixed cells) (25). Thyrocytes were identified by Tg immunofluorescence (Novocastra; 1:65). The nucleus was counterstained with 4Ј,6-diamidino-2-phenylindole (DAPI) (Sigma; 1:100).
Iodide uptake
Iodide uptake was measured according to Dohan et al. (29); some replicates were terminated at this point (intracellular 125 I content 100%), whereas in the other replicates, the medium was replaced at 5, 15, and 25 min as described (29). Radioactive medium was quantitated, and results are expressed as percentage of intracellular content. Finally, cells were lysed for quantitation of 125 I. Kinetic curves were fitted by nonlinear least-square regression using GraphPad Prism software based on the Michaelis-Menten equation. All parameters were determined at least in triplicate in three independent experiments. 
Thyroid function tests
TSH, FT 4 , and FT 3 were measured by chemiluminescence using ADVIA Centaur (Bayer Diagnostics, Tarrytown, NY). Tg, TgAb, and TPOAb were measured using Immulite 2000 (Diagnostic Products Corp., Los Angeles, CA). rT 3 was measured by RIA (Biocode Hycel, Liege, Belgium).
Statistical analysis
One-way ANOVA with post hoc comparisons by Student's t test and the Wilcoxon signed-rank test were used for statistical analysis.
Results
Genetic studies
The family-A proposita was heterozygous for c.279delT and c.578C3T.Mutationc.279delT,athymidinedeletionlocatedinexon 3 ( Fig. 1C) , causes a frameshift that introduces a stop codon three amino acids downstream (p.Ser93ArgfsX3). Mutation c.578C3 T (Fig. 1D) , located in exon 5, results in replacement of the normal threonine with an isoleucine at codon 193 (p.Thr193Ile) in the third membrane region of pendrin. The proposita inherited mutation c.578C3 T from her mother. No mutations were found in the proposita's sister, and no DNA samples were available from her father or two brothers.
The family B propositus was heterozygous for c.279delT (see above) and for c.416-1G3A, located at the acceptor splice site of intron 4, leading to replacement of the normal guanosine with an adenosine. His mother had the same compound heterozygous genotype (c.279delT, c.416-1G3A) and his father was homozygous for c.416-1G3A (Fig. 2) . Two of the father's siblings (IIIB.1 and IIIB.2, Fig. 2 ) showed profound deafness and were homozygous for c.416-1G3A. Subject IIIB.3 ( Fig. 2) did not have SLC26A4 mutations and showed much less severe deafness.
Mutations c.279delT, c.578C3T, and c.416-1G3A were not found in 120 alleles from 60 normal thyroid tissue samples obtained from Galician patients or in 100 alleles from 50 blood samples obtained from normal Galician volunteers aged between 20 and 60 yr.
Members of the two families bearing c.279delT shared the same haplotype, which was not present in unaffected individuals (Fig.  2) . Regarding c.416-1G3A, both affected and unaffected members of family B share a common haplotype not found in family A (Fig. 2) .
PCR amplification of propositus B thyroid SLC26A4 cDNA, extending from exon 3 to exon 6, gave the expected 500-bp product and a 420-bp product. A similar result was obtained using fibroblast cDNA from this propositus. In control thyroid tissue, only a 500-bp product was observed. The 500-bp fragment corresponded to three transcripts (Table 1) : a 499-bp transcript [r.279delt (37.5%)] resulting from thymidine deletion at nucleotide 279, a 499-bp transcript [r.416 -1 g3a;416_417del (25%)] resulting from an abnormal splicing one base from the regular splicing site, and an unexpected 500-bp wild-type transcript (37.5%). The 420-bp fragment likewise corresponded to two transcripts, of 420 and 417 bp, that resulted from abnormal splicing 79 and 82 bp from the regular site (r.416 -1 g3a; 416_495del, 416_498del). All the abnormal transcripts introduced premature stop codons.
Deiodinase and MCT8 levels
Deiodinase mRNA expression and activities were higher in the thyroid gland of the A proposita than in most control thyroid tissues (Table 2 ). MCT8 mRNA expression was also high in the proposita's thyroid (Table 2) . Thyroid hormone contents in con-
FIG. 3.
A, Gross appearance of right thyroid lobe from the propositus of family B; B and C, hematoxylineosin stain of thyroid tissue from the propositi of family A (B) and family B (C); D and E, lack of apical membrane staining for pendrin with PS1Ab, an antibody against the first 15 amino acids of human pendrin, with perinuclear enhanced halo in thyroid follicle cells from the propositi of family A (D) and weak cytoplasmic staining in family B (E); F, strong apical membrane PS1Ab staining is seen in Graves' disease; G-I, Tg and TPO immunoreactivity (inset) was found in both propositi and control thyroid glands: the proposita of family A (G), the propositus of family B (H), and Graves' disease (I). All original magnifications, ϫ200.
FIG. 4.
At the outer plasma membrane, normal thyrocytes (NT) express fully glycosylated NIS and pendrin, whereas cells from the propositus of family B (T-PS2) express only NIS. A, The appearance of cultured NT (a) and T-PS2 cells (b) is similar under the phase-contrast microscope. The cells are small and polygonal and leave round spaces between them, recalling a follicular structure (see arrows). In both cell lines, using DAPI for nuclear counterstaining, practically all cells expressed Tg (shown for T-PS2, c and d). B, Western blotting against NIS (left) and pendrin (right) using hot SDS extracts enriched in plasma membrane proteins (membrane) or 1% Triton extracts with intracellular membrane content, i.e. Golgi or ER (cytoplasmic). As a loading control, the membranes were rehybridized against tubulin. NIS is expressed mainly as the 100-kDa fully glycosylated form at the plasma membrane in NT, T-PS2, and the T-FA6 primary-culture follicular adenoma line from our BANTTIC collection; smaller bands around 80 kDa correspond to nonglycosylated immature NIS. Intracellular levels are undetectable in all lines except NT, in which a faint band can be seen suggesting slightly greater NIS expression. Mouse 3T3 fibroblasts were used as negative control. NT cells express the 130-kDa fully glycosylated pendrin at the plasma membrane, but only a very weak band (less than 5%) can be seen in T-PS2 and T-FA6 cells. The faint 85-kDa band is the nonglycosylated protein. In trol thyroid glands were 2-160 g/g for T 4 and 2-42 g/g for T 3 . In the proposita's thyroid, T 4 and T 3 content was 0.09 and 0.05 g/g, respectively.
Histology and immunohistochemistry
Thyroid glands from the two propositi showed similar microscopic appearance (Fig. 3) . The thyroid tissue and hyperplastic nodules were hypercellular, with normal and microfollicular areas along with some fibrous septae. Tall columnar cells in the follicles and scattered cells with nuclear atypia, characterized by enlargement and hyperchromasia, were also seen. Immunohistochemical findings were likewise similar in the two propositi (Fig. 3) ; follicular cells contained thyroid transcription factor-1, Tg, TPO, CK (CK7, AE1-AE3), and vimentin and were negative for calcitonin, CK20, and galectin-3.
Follicles from normal thyroid gland and from Graves' disease ( Fig. 3F) showed pendrin1 immunoreactivity (PS1Ab) in the luminal/apical border. Thyroid tissue from proposita B was negative at the apical membrane and weakly stained follicular cytoplasm (Fig. 3E) , suggesting that truncated proteins from alleles c.279delT and c.416 -1G3 A were either unstable or down-regulated. Thyroid tissue from proposita A was negative at the apical membrane but presented a perinuclear enhanced halo (Fig.  3D) , suggesting that full-length pendrin from allele c.578C3 T was stable although retained in intracellular perinuclear organelles (ER and Golgi).
Cell cultures, immunoblotting, and immunofluorescence analysis
T-PS2, a thyrocyte cell line compound heterozygous for c.279delT and c.416 -1G3 A, was obtained from a thyroid specimen of the B propositus and compared with a line of normal human thyrocytes, NT, from our bank (BANTTIC) (26, 27). Both cell lines have similar polygonal epithelial appearance, making follicle-like rounded structures (see Fig. 4A, a and b) . More than 90% of the thyrocytes in both lines expressed Tg (Fig.  4A, c and d ). Doubling times were also similar (around 23 h).
The NT and T-PS2 cell lines showed similar levels of glycosylated plasma-membrane NIS (Fig. 4B) , higher than T-FA6 cells (Fig. 4B) . NT cells showed high levels of glycosylated plasmamembrane pendrin (around 130 kDa) and a weaker cytoplasmic band corresponding to pendrin in the process of sorting (Fig. 4B) . A smaller band around 85 kDa corresponds to nonglycosylated immature pendrin. T-PS2 cells showed a very weak band of glycosylated pendrin, in both membrane and cytoplasmic extracts, suggesting intracellular retention of the scarce normal pendrin (Fig. 4B) . Negative control 3T3 mouse fibroblasts did not express pendrin, but a smaller band around 80 kDa was observed (Fig. 4B) . Interestingly, T-FA6 cells that expressed a faint band at the plasma membrane showed strong intracellular expression of pendrin (Fig. 4B) . The presence of a small quantity of normal protein agrees with the results mentioned above on the effect of c.416 -1G3 A on SLC26A4 splicing (see Table 1 ); as noted, mutation c.416 -1G3 A showed incomplete penetrance leading to a marked decrease but not complete disappearance of the normal pendrin transcript.
Confocal immunofluorescence studies with PS1Ab showed staining of NT thyrocytes at a point near the nucleus in the Golgi location and in narrow lines typical of plasma membrane localization (Fig. 4C, e and f) . Almost all T-PS2 thyrocytes showed the spot near the nucleus (Fig. 4C, g and h) , but no lines were detected, indicating either that normal and truncated proteins were both retained in the Golgi or that the concentration of normal pendrin is very low at the membrane. Recent results in our laboratory have shown low levels of pendrin mRNA expression in T-PS2 compared with NT (unpublished results), suggesting that the weak membrane expression of pendrin in T-PS2 could be related not only to defective membrane targeting but also to low transcription levels of the pendrin mutants.
We also studied the colocalization of NIS and pendrin (using PS1Ab against pendrin1 and PS5Ab against pendrin5). In normal thyrocytes, both NIS and pendrin1 showed a linear staining typical of plasma membrane localization (Fig. 4D, i-l) . However, the two proteins were usually not expressed in the same membrane patches, as can be seen from the scarce colocalization in the projections and the z planes. In T-PS2 thyrocytes, NIS was also located in the plasma membrane, but pendrin1 showed very few spots outside the Golgi (Fig. 4D, m-p) . Next, we repeated the colocalization studies using PS5Ab, recognizing the last 13 carboxyl-terminal amino acids of human pendrin. In these studies, both NIS and pendrin showed linear staining in the NT thyrocytes, but again, each protein localized in its plasma membrane region, with little colocalization (Fig. 4D, q-t) . Although the cells were grown in monolayers, this arrangement recalls that of partially polarized thyrocytes. In the T-PS2 thyrocytes, despite the correctly localized membrane NIS, only weak pendrin spots were seen (Fig. 4D, u-y) .
Iodide uptake
NT cells showed fast iodide uptake, with cellular iodide content plateauing at 2 min and not changing over the remainder of the 30-min experiment (Fig. 5A) . The kinetics curve suggests that the two iodine transporters (NIS and pendrin) were working in opposite directions. NIS initiates iodide uptake, and once intraintracellular membranes, NT cells express a weak band corresponding to pendrin in the process of sorting, and T-PS2 cells likewise show only a weak band. However, T-FA6 cells retain pendrin intracellularly. C, Confocal immunofluorescence images using the same pendrin antibody as in B, PS1Ab (specific for the N-terminal part of the protein). DAPI is used to show nuclei. Both a ϫ40 water-immersion objective with ϫ3 magnification (e and g) and a ϫ63 oil-immersion objective with a ϫ1.5 magnification (f and h) were used. PS1Ab staining is localized in the Golgi (round spots beside the nuclei) and the plasma membrane (straight lines indicated by arrows) in normal thyrocytes (NT); in T-PS2 thyrocytes, pendrin appears to be retained in the Golgi (truncated proteins). D, Double immunofluorescence with NIS and PS1Ab shows intracellular and plasma membrane staining (arrows) of both proteins in NT (i-l, ϫ1000). Note that membrane colocalization is not frequent: the z projections obtained through stacking of confocal images show that, although localized in the membrane, the two proteins rarely coincide in the same locations, as indicated by the scarce yellow spots. T-PS2 cells (m-p, ϫ1000) show intracellular and plasma membrane staining of NIS, but only one isolated spot of pendrin can be seen at the plasma membrane, whereas the rest is retained in the Golgi. Similar double-immunofluorescence studies were performed using PS5Ab, specific for the C-terminal end of the pendrin protein. Both NIS and pendrin are localized at the plasma membrane in NT cells (q-t, ϫ1000), although both proteins seem to occupy different membrane domains (see z projections). In T-PS2 cells, the PS5Ab image is overexposed to demonstrate the absence of specific staining (u-y).
cellular iodide concentration reaches a certain level, pendrin will start efflux, maintaining the amount of iodide inside the thyrocyte at a constrained level. In contrast, T-PS2 cells showed a progressive increase in iodide level, which plateaued at around 15 min (Fig. 5A ), in accordance with a single transporter (NIS) model. Vmax was two times higher in T-PS2 than NT cells, suggesting that iodide was accumulated in T-PS2 thyrocytes. In fact, the steady-state uptake after 30 min was higher in T-PS2 than NT thyrocytes (Fig. 5B) .
Efflux was faster from NT than from T-PS2 cells (Fig. 5C,  left) . At 5 min, 40% of radioactivity had already effluxed from NT cells, but no significant efflux was seen from T-PS2; by 15 min, almost all radioactivity had effluxed from NT cells, but 40% remained in T-PS2. When residual iodide was measured at the end of the experiment, T-PS2 cells maintained higher intracellular iodide than NT cells (Fig. 5C, right) .
Dose-response curves showed that after 5 min, T-PS2 cells had already reached equilibrium for iodide uptake with a MichaelisMenten constant (K m ) similar to that expected for NIS at equilibrium (22 Ϯ 4.8 M) (Fig. 6) . In contrast, NT cells achieved equilibrium and the expected K m for iodide uptake at 1 h. Except at very short times of incubation (30 sec), when Vmax was higher for NT cells, the Vmax was twice as high in T-PS2 thyrocytes at any given time. These results suggest that normal thyrocytes behave as a complex system in which both transporters (NIS and pendrin) need to reach equilibrium slowly and that intracellular iodide concentrations are not high; however, PS-affected thyrocytes accumulate iodine through NIS, and iodine leaves the cell inefficiently through other nonspecific transporters.
Discussion
Two Galician families with PS were studied. SLC26A4 gene sequences showed two previously described mutations, c.279delT (8, 17) and c.578C3 T (11, 16) and a novel mutation c.416 -1G3 A. Both families had the c.279delT mutation, and a common haplotype was seen only in c.279delT carriers, suggesting a founder effect for this mutation. Galicians have low genetic diversity in comparison with other European populations, and founder effects are not uncommon (30).
The c.416 -1G3 A mutation was present in family B. Although the parents denied that they were related, they were born in the same village, and a common haplotype for c.416-G3 A was found in both affected and unaffected family B members but not in haplotyped members of family A. Until recently, the Galician population was organized in small and relatively isolated groups, and it is likely that the parents of propositus B have a common ancestor. The fact that this mutation has not been previously reported also suggests that c.416 -1G3 A originated in Galicia.
We believe that the phenotype of the A proposita (large goiter, normal serum TSH and FT 3 , and hypothyroxinemia) is an adaptive response to poor organification. In experimental animals, iodine-deficient diet increases thyroid weight and favors the synthesis and secretion of T 3 resulting in an increase in serum and tissue T 3 /T 4 ratio (31, 32). These changes are partially due to a TSH-independent increase in T 3 generation (32), which can lead to low serum T 4 , with normal or slightly elevated T 3 and normal TSH (31). In our patient, due to the marked increase in thyroid gland size, the raised D1 and D2 levels were sufficient to maintain FIG. 5. T-PS2 thyrocytes take up iodide and retain it intracellularly. A, Time course of iodide uptake (20 M NaI) by thyrocyte lines. Normal NT cells show fast uptake in the first 30 sec, reaching a plateau at 2 min, with no further changes in intracellular iodine content over the remainder of the 30-min experiment (r 2 ϭ 0.65); the kinetic curve suggests that, during the first 2 min, NIS transports iodide into NT thyrocytes but that iodide is then effluxed from the cells through pendrin, with the two transporters (NIS and pendrin) then working in opposite directions to maintain equilibrium. In contrast, T-PS2 cells show a progressive increase in iodide uptake, reaching a plateau much later (r 2 ϭ 0.99), suggesting a model with a single transporter (NIS); in fact, there were significant differences in intracellular iodine content between the time points 2 or 5 min and the time points 15 or 30 min. Vmax was twice as high for T-PS2 thyrocytes as for NT. B, Steady-state uptake of NaI after incubation for 30 min. At any given concentration of NaI, the intracellular iodide uptake by T-PS2 thyrocytes (black bars) was twice as high as by NT (white bars). In both cell lines, coincubation with 40 M NaClO 4 blocked the iodide uptake (striped bars). C, Efflux of iodide into the culture medium expressed as a percentage of the amount obtained at time 0 after the steady-state uptake using 20 M NaI. NT thyrocytes released all radioactive iodine to the medium after 15 min of initial washing. T-PS2 released the radioactive iodine much more slowly, so that after 15 min, 40% still remained inside the cells (P Ͻ 0.01). Efflux stopped at 25 min, but the residual amount inside the cell at that time was significantly higher in T-PS2 cells (black bars) than in NT cells (white bars).
normal levels of serum FT 3 . D1 and D2 will increase the intrathyroidal conversion of T 4 into T 3 , and MCT8 will maintain the transport of thyroid hormones across thyrocytes. Interestingly, the proposita's L-thyroxine requirements were increased after thyroidectomy due to loss of the thyroid as a source of T 3 . A transient increase in serum TSH in response to low thyroid hormone synthesis is a straightforward explanation for goiter development in PS patients, although other mechanisms could be involved. T-PS2 cells showed increased iodide retention leading to a steady intracellular iodide concentration. This finding suggests that intracellular accumulation of iodide may occur in thyrocytes of PS patients with adequate iodine intake, and this could have a role in the functional changes seen in diseased Pendred thyrocytes. High dietary iodine intake promotes goiter in humans (33) , and although the mechanisms are not clearly defined, the Wolff-Chaikoff effect seems to play a role. However, a direct stimulating action of iodine on thyrocyte proliferation is also possible. Very high NaI concentrations (10 -50 mM) over several days inhibited the proliferation of cultured rat FRTL-5 thyrocytes (34), but this was probably a toxic effect. In contrast, physiological concentrations (1 M KI, equivalent to 150 g/liter) stimulated basal and epidermal growth factor-induced proliferation in primary cultures of porcine follicles (35, 36) through down-regulation of intracellular cAMP levels.
Family B's clinical phenotype is complicated by the finding of deafness with and without SLC26A4 mutations. Also, homozygotes for c.416 -1G3 A have congenital deafness, but not all have goiter. In fact, neither goiter nor thyroid hormone abnormalities were found in the father of the propositus, homozygous for c.416 -1G3 A. A similar situation has been recently reported in deaf people homozygous or compound heterozygous for mutations in SLC26A4 (5). Absence of goiter and the mild thyroid organification defect in the propositus' father suggests that iodine can cross the apical border of thyroid cells. This can be explained by alternative splicing of the mutated mRNA, maintaining a limited amount of normal transcript. Alternatively, some iodine passage may occur through diffusion, as in the basolateral transport when NIS is absent, or another apical iodine transporter may take on pendrin's function (37) . In fact, studies in our T-PS2 thyrocytes showed that intracellular iodide was able to leave the cell, although more slowly and less efficiently than from normal NT thyrocytes.
The lack of apical pendrin immunoreactivity in the two propositi suggests that pathogenesis in our patients was due not only to functional impairment of pendrin but also to defective plasma membrane targeting (38, 39) : T-PS2 thyrocytes did not express enough mature pendrin, as indicated by Western blotting and immunofluorescence, although some mature protein was pro- Except at very short incubation times (30 sec), when Vmax was higher in NT cells, Vmax was about twice as high in T-PS2 thyrocytes at any given time. This result suggests that initially only the NIS transporter is working in NT, as in T-PS2, but that after a few seconds pendrin starts to work in NT, and equilibrium is reached later.
duced by alternative splicing. T-PS2 cells also showed Golgi immunofluorescence, indicating retention of severely truncated proteins inside Golgi structures, as reported for other pendrin mutants in transfection studies (38, 39) . Interestingly, T-FA6 cells overexpress mature pendrin, although it seems to be retained intracellularly, a finding that could be important in the pathophysiology of cold adenomas.
In conclusion, we have described two families with PS from Galicia. The founder mutation c.279delT was detected in both families. A novel mutation, c.416 -1G3 A, affecting SLC26A4 splicing, was also found; absence of goiter in subjects homozygous for this mutation could be explained by incomplete penetrance. Some affected subjects have goiter with normal TSH and normal thyroid hormones or hypothyroxinemia. An increase in D1 and D2 expression and activity and in MCT8 expression was found in thyroid tissue of the proposita of family A. These changes are adaptive responses to maintain a normal T 3 supply at the expense of T 4 . No pendrin immunoreactivity was seen at the luminal border of follicles in the propositi's thyroid glands, and T-PS2 thyrocytes showed pendrin retention in Golgi structures, indicating that mutations affect targeting of pendrin to the plasma membrane. Pendred-affected thyrocytes showed low iodide efflux and consequent accumulation, confirming the importance of pendrin as an iodide transporter.
